Nocturnal urine melatonin and 6-sulphatoxymelatonin excretion at the acute stage of ischaemic stroke

Journal of Pineal Research

Volumn 46, Issue 3, 2009, Pages 349-352

  Ritzenthaler, Thomas ^b   Nighoghossian, Norbert ^b,c   Berthiller, Julien ^b,c   Schott, Anne Marie ^b,c   Cho, Tae Hee ^b   Derex, Laurent ^b   Brun, Jocelyne ^b   Trouillas, Paul ^b   Claustrat, Bruno ^a,b,c  

^a Groupement Hospitalier Est   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

6 sulphatoxymelatonin; Excretion; Melatonin; Stroke

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IMMUNOSUPPRESSIVE AGENT; MELATONIN; STEROID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; POPULATION; RADIOIMMUNOASSAY; SEX DIFFERENCE; TUMOR VOLUME; URINALYSIS; URINE;

EID: 62449196407     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2009.00670.x     Document Type: Article

References (19)

1. Paakkonen T, Makinen TM, Leppaluoto J et al. Urinary melatonin: a non-invasive method to follow human pineal function as studied in three experimental conditions. J Pineal Res 2006 40 : 110 115.
2. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005 9 : 11 24.
3. Rennie K, De Butte M, Frechette M, Pappas BA. Chronic and acute melatonin effects in gerbil global forebrain ischemia: long-term neural and behavioral outcome. J Pineal Res 2008 2 : 149 156.
4. Carloni S, Perrone S, Buonocore G, Longini M, Proietti F, Balduini W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008 2 : 157 164.
5. Koh PO. Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3. J Pineal Res 2008 1 : 101 106.
6. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998 3 : 359 384.
7. Lee MY, Kuan YH, Chen HY et al. Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. J Pineal Res 2007 42 : 297 309.
8. Benot S, Goberna R, Reiter RS et al. Physiological levels of melatonin contribute to the antioxydant capacity of human serum. J Pineal Res 1999 27 : 59 64.
9. Fiorina P, Lattuada G, Ponari O et al. Impaired nocturnal melatonin excretion and changes of immunological status in ischemic stroke patients. Lancet 1996 347 : 692 693.
10. Beloosesky Y, Grinblat J, Laudon M, Grosman B, Streifler JY, Zisapel N. Melatonin rhythms in stroke patients. Neurosci Lett 2002 319 : 103 106.
11. Brun J, Claustrat B, David M. Urinary melatonin, LH, oestradiol, progesterone excretion during the menstrual cycle or in women taking oral contraceptives. Acta Endocrinol 1987 116 : 145 149.
12. Harthe C, Claustrat B, Brun J, Chazot G. Direct 6-sulfatoxymelatonin radioimmuno-assay in plasma with use of an iodinated tracer. Clin Chem 1991 37 : 536 539.
13. Tukey J. Exploratory Data Analysis. Addison-Wesley Publishing Company, Inc., Reading, MA, 1977.
14. Meng H, Liu T, Borjigin J, Wang MM. Ischemic stroke destabilizes circadian rhythms. J Circadian Rhythms 2008 6 : 9.
15. Maldonado MD, Murillo-Cabezas P, Terron MP et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res 2007 42 : 1 11.
16. Tan DX, Manchester LC, Terron MP, Floresh J, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and reactive nitrogen species. J Pineal Res 2007 42 : 28 42.
17. Peyrot F, Ducrocq C. Potential of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J Pineal Res 2008 45 : 235 244.
18. Cervantes M, Morali G, Letechipia-Vallejo G. Melatonin and ischemia-reperfusion of the brain. J Pineal Res 2008 45 : 1 7.
19. Ma X, Idle JP, Krausz KW, Tan DX, Ceraulo L, Gonzalez FJ. Urinary metabolites and antioxidant products of exogenous melatonin in the mouse. J Pineal Res 2006 40 : 343 349.